These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 22313031)
1. Fibroblast growth factor receptor 4 polymorphisms and susceptibility to coronary artery disease. Ma L; Zhang H; Han C; Tong D; Zhang M; Yao Y; Luo Y; Liu X DNA Cell Biol; 2012 Jun; 31(6):1064-9. PubMed ID: 22313031 [TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor receptor 4 polymorphisms and coronary artery disease: a case control study. Zhu Q; Liu T Mol Biol Rep; 2012 Sep; 39(9):8679-85. PubMed ID: 22696188 [TBL] [Abstract][Full Text] [Related]
3. Association between fibroblast growth factor receptor 4 Gly388Arg polymorphism and ischaemic stroke. Zhang HF; Zhao KJ; Yang PF; Fang YB; Zhang YH; Liu JM; Huang QH J Int Med Res; 2012; 40(5):1708-14. PubMed ID: 23206452 [TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor receptor 4 polymorphisms are associated with coronary artery disease. Chen H; Tong J; Zou T; Shi H; Liu J; Du X; Yang J; Ma C Genet Test Mol Biomarkers; 2012 Aug; 16(8):952-6. PubMed ID: 22587598 [TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor receptor 4 polymorphisms and the prognosis of non-Hodgkin lymphoma. Cha Z; Zang Y; Guo H; Gu H; Tu X; Song H; Qian B Mol Biol Rep; 2014 Feb; 41(2):1165-70. PubMed ID: 24381107 [TBL] [Abstract][Full Text] [Related]
6. Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis. Xiong SW; Ma J; Feng F; Fu W; Shu SR; Ma T; Wu C; Liu GC; Zhu J Oncotarget; 2017 Apr; 8(15):25300-25309. PubMed ID: 28445975 [TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor receptor 4 polymorphism is associated with increased risk and poor prognosis of non-Hodgkin's lymphoma. Gao L; Feng Z; Li Q; Li L; Chen L; Xiao T Tumour Biol; 2014 Apr; 35(4):2997-3002. PubMed ID: 24248544 [TBL] [Abstract][Full Text] [Related]
8. An updated meta-analysis of the association between fibroblast growth factor receptor 4 polymorphisms and susceptibility to cancer. Moazeni-Roodi A; Sarabandi S; Karami S; Hashemi M; Ghavami S Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33017009 [TBL] [Abstract][Full Text] [Related]
9. Gender-Specific Association Between FGFR4 Gly388Arg Gene Variants and Hypertension. Al-Daghri NM; Mohammed AK; Al-Attas OS; Draz HM; Alokail MS Genet Test Mol Biomarkers; 2017 Jul; 21(7):422-427. PubMed ID: 28650667 [TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor receptor 4 Gly388Arg polymorphism in Chinese gastric cancer patients. Shen YY; Lu YC; Shen DP; Liu YJ; Su XY; Zhu GS; Yin XL; Ni XZ World J Gastroenterol; 2013 Jul; 19(28):4568-75. PubMed ID: 23901234 [TBL] [Abstract][Full Text] [Related]
12. Association of Fibroblast Growth Factor Receptor 4 Genetic Polymorphisms With the Development of Uterine Cervical Cancer and Patient Prognosis. Chen TH; Yang SF; Liu YF; Lin WL; Han CP; Wang PH Reprod Sci; 2018 Jan; 25(1):86-93. PubMed ID: 28378614 [TBL] [Abstract][Full Text] [Related]
13. Association of FGFR3 and FGFR4 gene polymorphisms with breast cancer in Chinese women of Heilongjiang province. Jiang Y; Sun S; Wei W; Ren Y; Liu J; Pang D Oncotarget; 2015 Oct; 6(32):34023-9. PubMed ID: 26431494 [TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of TGFβ-1 and TGFBR2 in relation to coronary artery disease in a Chinese population. Yang M; Zhu M; Tang L; Zhu H; Lu Y; Xu B; Jiang J; Chen X Clin Biochem; 2016 Aug; 49(12):873-8. PubMed ID: 27234600 [TBL] [Abstract][Full Text] [Related]
15. IMPACT OF FGFR4 (GLY388ARG) GENE POLYMORPHISM ALONG WITH VISFATIN CYTOKINE AND HIGH MOBILITY GROUP BOX-1 (HMGB1) ON ACUTE CHOLECYSTITIS. Alfuaadi IH; Altamemi IA Wiad Lek; 2022; 75(5 pt 2):1242-1247. PubMed ID: 35758438 [TBL] [Abstract][Full Text] [Related]
16. Association between fibroblast growth factor receptor 4 polymorphisms and risk of hepatocellular carcinoma. Yang Y; Zhou Y; Lu M; An Y; Li R; Chen Y; Lu DR; Jin L; Zhou WP; Qian J; Wang HY Mol Carcinog; 2012 Jul; 51(7):515-21. PubMed ID: 21656577 [TBL] [Abstract][Full Text] [Related]
17. Prognostic implications of fibroblast growth factor receptor 4 polymorphisms in primary breast cancer. Wei W; You Z; Sun S; Wang Y; Zhang X; Pang D; Jiang Y Mol Carcinog; 2018 Aug; 57(8):988-996. PubMed ID: 29603419 [TBL] [Abstract][Full Text] [Related]
18. [Association of C1019T polymorphism in the connexin 37 gene and coronary artery disease in Chinese Han population]. Han YL; Xi SY; Zhang XL; Yan CH; Yang Y; Kang J Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(2):100-4. PubMed ID: 17418016 [TBL] [Abstract][Full Text] [Related]
19. Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor. Frullanti E; Berking C; Harbeck N; Jézéquel P; Haugen A; Mawrin C; Parise O; Sasaki H; Tsuchiya N; Dragani TA Eur J Cancer Prev; 2011 Jul; 20(4):340-7. PubMed ID: 21412156 [TBL] [Abstract][Full Text] [Related]
20. FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung. Falvella FS; Frullanti E; Galvan A; Spinola M; Noci S; De Cecco L; Nosotti M; Santambrogio L; Incarbone M; Alloisio M; Calabrò E; Pastorino U; Skaug V; Haugen A; Taioli E; Dragani TA Int J Cancer; 2009 Jun; 124(12):2880-5. PubMed ID: 19296538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]